Search results for " cost"
Article
Reducing Cross-Contamination Risks in Process Chromatography
“When it comes to new facilities, the small footprint and easy-to-use format of the products reduces investment needs with respect to facility, equipment, and labor, enabling cost savings and faster t…
Article
Improving Process-Scale Chromatography
By Cynthia Challener, PhD
Chromatography is a crucial step in the purification of biopharmaceuticals and accounts for a significant portion of downstream processing efforts (time and cost) for bio…
Article
Platform Approach Speeds Process Development
Minimal early development effort, however, may induce increased challenges in late-stage process development that may result in unnecessary costs and delays.
For comprehensive process development, i…
Article
Tools for Continuous Bioprocessing Development
Because typical perfusion process experiments consume 1–3 working volumes per day and can run for 20–60 days, culture media costs alone contribute to prohibitively expensive experimental campaigns. Fo…
Article
Changing the Culture of Cell Culture: Applying Best Practices and Authentication to Ensure Scientific Reproducibility
Neve
Irreproducible preclinical research is a global, expensive, and well-recognized problem that contributes to delays and increased costs of drug discovery (1, 2). One published study conservati…
Article
EMA Collaborates with HTA Assessment Networks
While the regulatory agencies deal with benefit-risk aspects of medicines, HTA bodies gauge their effectiveness in relation to existing products, particularly on the basis of cost.
The role of t…
Article
HT Multi-Product Liquid Chromatography for Characterization of Monoclonal Antibodies
By taking a holistic approach to improving the analytical process, one can identify strategies to increase throughput and reduce development times and the costs of analytical methods. This article dis…
Article
Overview of a scale-up of a cell-based influenza virus production process using ReadyToProcess equipment
Several of the vaccines we consider to be the base in today’s Western immunization programs have not yet reached the developing world as there are many barriers to overcome, such as production cost, l…
Article
The Future of Biopharma
Innovation speeds discovery, drives down costs, and improves productivity. The current situation in the biopharmaceutical industry is exciting enough, with biosimilars, new technologies, personalized …
Article
New Therapies Present Scaling Challenges
With a cell therapy, however, establishing cost-effective ways to commercially manufacture cell therapies for mainstream use remains a challenge. For a gene therapy, some aspects of its manufacturing …